Low dose selegiline (L-Deprenyl) in social phobia

Depression and Anxiety

Volumn 7, Issue 3, 1998, Pages 126-129

  Simpson, H Blair ^a,b   Schneier, Franklin R ^a,b   Marshall, Randall D ^a,b   Campeas, Raphael B ^a,b   Vermes, Donna ^a   Silvestre, Joao ^a   Davies, Sharon ^a   Liebowitz, Michael R ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SELEGILINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SCREENING; FEMALE; HUMAN; MALE; OUTPATIENT CARE; PATIENT SELECTION; PRIORITY JOURNAL; SOCIAL PHOBIA;

ADULT; ANALYSIS OF VARIANCE; FEMALE; HUMANS; MALE; MONOAMINE OXIDASE INHIBITORS; PHOBIC DISORDERS; PSYCHIATRIC STATUS RATING SCALES; REMISSION INDUCTION; SELEGILINE; SOCIAL ADJUSTMENT;

EID: 0031834846     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6394(1998)7:3<126::AID-DA5>3.0.CO;2-9     Document Type: Article

References (24)

1. Barrett JS, Hochadel TJ, Morales RJ, Rohatagi S, DeWitt KE, Watson SK, DiSanto AR (1996) Pharmacokinetics and safety of a selegiline transdermal system relative to single-dose oral administration in the elderly. Am J Therapeutics 3:688-698.
2. Barret JS, Hochadel TJ, Morales RJ, Rohatagi S, DeWitt KE, Watson SK, Darnow J, Assaro AJ, DiSanto AR (1997) Pressor response to tyramine after single 24-hour application of a selegiline transdermal system in healthy males. J Clin Pharm 37:238-247.
3. Davidson JR, Potts N, Richichi E, Krishnan R, Ford SM, Smith R, Wilson WH (1993) Treatment of social phobia with clonazepam and placebo. J Clin Psychopharm 13:423-428.
4. Gelernter CS, Uhde TW, Cimbolic P, Arnkoff DB, Vittone BJ, Tancer ME, Bartko JJ (1991) Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study. Arch Gen Psychiatry 48:938-945.
5. Gerlach M, Youdim MBH, Riederer P (1996) Pharmacology of selegiline. Neurology 47 (Suppl 3): S137-S145.
6. Guy W (1976) ECDEU Assessment Manual of Psychopharmacology. Washington, DC: DHEW.
7. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiat 23:56-62.
8. Katselnick DJ, Kobak KA, Greist JH, Jefferson JW, Mantal JM, Serlin RC (1995) Sertraline for social phobia: A double-blind, placebocontrolled crossover study. Am J Psychiatry 152:1368-1371.
9. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen H, Kendler KS (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Cormorbidity Survey. Arch Gen Psychiatry 51:8-19.
10. Krishnan KRR (1995) Monoamine Oxidase Inhibitors. In: Schatzberg AF, Nemeroff CB (eds): The American Psychiatric Press Textbook of Psychopharmacology. Washington, DC: American Psychiatric Press, Inc., pp 183-193.
11. Lefebure H, Moblet C, Moore N, Wolf LM (1995) Pseudophaeochromocytoma after multiple drug interactions involving the selective monoamine oxidase inhibitor selegiline. Clinical Endocrinology 42:95-99.
12. Liebowitz MR (1987) Social phobia. Mod Probl Pharmocopsychiatry 22:141-173.
13. Liebowitz MR, Schneier F, Campeas R, Hollander E, Hatterer J, Fyer A, Gorman J, Papp L, Davies S, Gully R, Klein DF (1992) Phenelzine vs atenolol in social phobia: A placebo-controlled comparison. Arch Gen Psychiatry 49:290-300.
14. Marshall RD, Schneier FR (1996) An algorithm for the pharmacotherapy of social phobia. Psychiatric Annals 26:210-216.
15. Munjack DJ, Baltazar PL, Bohn PB, Cabe DD, Appelson AA (1990) Clonazepam in the treatment of social phobia: A pilot study. J Clin Psychiatry 51 (suppl):35-40.
16. Ontiveros A, Fontaine R (1990) Social phobia and clonazepam. Can J Psychiatry 35:439-441.
17. Potts NLS, Davidson JRT (1992) Social phobia: Biological aspects and pharmacotherapy. Prog Neuro-Psychopharmacol Biol Psychiat 16:635-646.
18. Reiter SR, Pollack MH, Rosenbaum JF, Cohen LS (1990) Clonazepam for the treatment of social phobia. J Clin Psychiatry 51-470-472.
19. Schneier FR, Johnson J, Hornig CD, Liebowitz MR, Weissman MM (1992) Social phobia: Comorbidity and morbidity in an epidemiologic sample. Arch Gen Psychiatry 49:282-288.
20. Schneier FR, Heckelman LR, Garfinkel R, Campeas R, Fallon BA, Gitow A, Street L, Del Bene D, Liebowitz MR (1994) Functional impairment in social phobia. J Clin Psychiatry 55:322-331.
21. Spitzer RL, Williams JBW, Gibbon M, First MB (1989) Structured Clinical Interview for DMS-III-R-Patient Version (SCIP-P) New York: New York State Psychiatric Institute, Biometrics Research.
22. Sunderland T, Mueller EA, Cohen RM, Jimerson DC, Pickar D, Murphy DL (1985) Tyramine pressor sensitivity changes during deprenyl treatment. Psychopharmacology 86:432-437.
23. Sunderland T, Cohen RM, Molchan S, Lawlor BA, Mellow AM, New house PA, Tariot PN, Mueller EA, Murphy DL (1994) High-dose selegiline in treatment-resistant older depressive patients. Arch Gen Psychiatry 51:607-615.
24. Tiihonen J, Kuikka J, Bergstrom K, Lepola U, Koponen H, Leinonen F. (1997) Dopamine reuptake site densities in patients with social phobia. Am J Psychiatry 154:239-242.